Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: A Study on the Associations of Toll-like Receptor 5 Gene Polymorphisms With Crohn's Disease in Chinese Patients

View source ↗

Summary

This completed clinical trial investigates associations between Toll-like receptor 5 gene polymorphisms and Crohn's disease in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Second Affiliated Hospital of Wenzhou Medical University | Conditions: Crohn's Disease, Ustekinumab | Status: COMPLETED